MSB 6.07% $1.01 mesoblast limited

Overwhelming efficacy - the stats required, page-212

  1. 268 Posts.
    lightbulb Created with Sketch. 41
    It's a good question, not sure we have a good answer. Probably the elapsed time has not been long enough to form a good view on how Remestemcel-L is influencing ongoing sequelae.

    Some people are going to gradually going to get better without it, others may be permanently injured, and maybe data will emerge that Remestemcel-L treated patients fare better in this regard...

    Again in my view the best way forwards is a Phase 4 followup.

    I am very concerned that lung fibrosis in particular will become refractory within weeks / a month and difficult to treat~


    Last edited by jb13qz: 01/09/20
 
watchlist Created with Sketch. Add MSB (ASX) to my watchlist
(20min delay)
Last
$1.01
Change
-0.065(6.07%)
Mkt cap ! $1.147B
Open High Low Value Volume
$1.05 $1.05 $1.00 $5.702M 5.582M

Buyers (Bids)

No. Vol. Price($)
19 154906 $1.01
 

Sellers (Offers)

Price($) Vol. No.
$1.01 130151 20
View Market Depth
Last trade - 13.51pm 30/07/2024 (20 minute delay) ?
MSB (ASX) Chart
arrow-down-2 Created with Sketch. arrow-down-2 Created with Sketch.